Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response

Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response

US Patent 6667293 · Granted Dec 23, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for cancer imaging and radiotherapy2025
Therapeutic compositions for treating pain via multiple targets2024
Compositions and methods for cancer imaging and radiotherapy2023
Immune modulation with TLR9 agonists for cancer treatment2022
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2020
Immune modulation with TLR9 agonists for cancer treatment2019
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2018
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2018
Compositions for inhibiting checkpoint gene expression and uses thereof2017
Toll-like receptor 9 antagonist and methods of use thereof2017
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor2017